Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 4 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready
Tesla Biohealing Inc. maintains an active patent prosecution profile within the Biotechnology & Pharmaceuticals technology area. The company currently has 4 pending office actions, which are distributed across 3 distinct art units. This distribution indicates that the company's biotechnology innovations are being reviewed by several different specialized groups within the USPTO, reflecting a range of technical applications. The use of 3 distinct art units requires the company to adapt its legal and technical arguments to the specific standards of three different examination groups.
The prosecution workload is managed by 3 distinct examiners, with GWARTNEY, ELIZABETH A serving as the busiest examiner. GWARTNEY, ELIZABETH A is responsible for 2 busiest examiner pending office actions, while the remaining 2 pending office actions are split between the other distinct examiners. This provides some variety in examination styles across the portfolio. Managing 4 pending office actions across 3 distinct art units requires a coordinated strategy to ensure consistency in the company's intellectual property filings.
Practitioners must address the specific requirements of GWARTNEY, ELIZABETH A for a portion of the matters while simultaneously navigating the preferences of the other 2 distinct examiners. This structure allows the company to advance multiple patent goals within the Biotechnology & Pharmaceuticals sector while focusing a significant portion of its efforts on a single examiner's feedback. The 2 busiest examiner pending for GWARTNEY, ELIZABETH A highlights a point of consolidation in an otherwise distributed prosecution environment. This distribution among 3 distinct art units provides the company with a broad exposure to various USPTO examination practices.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (80%) |
| Double-patenting only | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GWARTNEY, ELIZABETH A | 2 | 36.0% | +34.9% |
| ARNOLD, ERNST V | 1 | 48.2% | +12.8% |
| TRUONG, QUANGLONG N | 1 | 78.6% | +23.3% |
| MONSHIPOURI, MARYAM | 1 | 79.2% | +37.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17409665 | Bioenergy (Biophoton) Generator and Its Use | MONSHIPOURI, MARYAM | 23d |
| 18780610 | Devices for Treating Diseases and Conditions | ARNOLD, ERNST V | — |
| 18735463 | BIOENERGY (BIOPHOTON) GENERATOR AND ITS USE | TRUONG, QUANGLONG N | — |
| 18380727 | Bioenergy (Biophoton) Generator and its Use | GWARTNEY, ELIZABETH A | — |
| 18374040 | A Bioenergy (Biophoton) Generator and its Use | GWARTNEY, ELIZABETH A | — |
| Art Unit | Apps |
|---|---|
| 1759 | 2 |
| 1613 | 1 |
| 1615 | 1 |
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18780610 | Devices for Treating Diseases and Conditions | ARNOLD, ERNST V | 1613 | DP | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18735463 | BIOENERGY (BIOPHOTON) GENERATOR AND ITS USE | TRUONG, QUANGLONG N | 1615 | §103 | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18380727 | Bioenergy (Biophoton) Generator and its Use | GWARTNEY, ELIZABETH A | 1759 | §103 | Non-Final OA | — | Pending | Oct 17, 2023 |
| 18374040 | A Bioenergy (Biophoton) Generator and its Use | GWARTNEY, ELIZABETH A | 1759 | §103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 17409665 | Bioenergy (Biophoton) Generator and Its Use | MONSHIPOURI, MARYAM | 1651 | §103 | Final Rejection | 23d | Pending | Aug 23, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTesla Biohealing Inc. has 5 pending office actions as of October 2026, spread across 4 art units and 4 examiners.
Elizabeth A Gwartney has the most, with 2 of Tesla Biohealing Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
